Organon (OGN) Price to Sales (2021 - 2026)

Organon has reported Price to Sales for 6 years, with the latest figure at 2.28 in Q2 2026.

• On a quarterly basis, Price to Sales rose 44.56% year-over-year to 2.28 in Q2 2026; TTM through Jun 2026 was 0.58, a 44.85% increase from a year earlier, with the FY2025 full-year figure at 0.3, down 50.01% from the prior year.
• Price to Sales was 2.28 for Q2 2026 at Organon, up from 1.08 in the prior quarter.
• The five-year high for Price to Sales was 5.65 in Q1 2022, with the low at 1.08 in Q1 2026.
• Average Price to Sales over 5 years is 3.02, with a median of 2.94 recorded in 2024.
• The largest YoY upside for Price to Sales was 44.56% in 2026 against a maximum downside of 57.55% in 2026.
• Over 5 years, Price to Sales stood at 4.78 in 2022, then slumped by 51.78% to 2.31 in 2023, then rose by 4.74% to 2.42 in 2024, then plunged by 48.74% to 1.24 in 2025, then jumped by 84.27% to 2.28 in 2026.
• The last three Price to Sales figures came in at 2.28 (Q2 2026), 1.08 (Q1 2026), and 1.24 (Q4 2025), per Business Quant data.